Ann: Paradigm Receives Ethics Approval for Ross River Trial, page-3

I've been buying this stock for a couple of weeks now. I am a veterinarian and all vets use bucket loads of PPS for treating joint disease in various species and I've always been astounded that there has been so little research as regards PPS in joint disease in humans....finally it's happening...this was my main reason for investing....the hayfever use and it's anti-inflammatory effects via the cytokine pathway is an eye opener and the market potential for both the hayfever and arthritis markets is truly staggeringly large.....1% penetration of these markets is sales of $0.5B.

I met Paul Rennie for a hr last tue and my thoughts on how this could be used in hunans based on the success of how I use it in animals, not just as a treatment but as a preventative, is exactly the pathways Paul is thinking long term. My email is below if you would like more information,

Kind regards, SEAH.